Communication
NJC
W. Schilling, J. Kollmann and S. Das, ACS Catal., 2018, 8,
6659–6664; (c) Y. Zhang, D. Reimer, W. Schilling,
J. Kollmann and S. Das, Nat. Protoc., 2020, 15, 822–839;
(d) W. Schilling and S. Das, et al., Chem. – Eur. J., 2020, 26,
390–395; (e) Y. Zhang and S. D. Schilling, et al., Chem-
SusChem, 2019, 12, 2898–2910.
3 (a) S. Y. Han and Y. A. Kim, Tetrahedron, 2004, 60,
2447–2468; (b) C. A. G. N. Montalbetti and V. Falque, Tetra-
hedron, 2005, 61, 10827–10852; (c) E. Valeur and M. Bradley,
Chem. Soc. Rev., 2009, 38, 606–631; (d) R. C. Larock, Com-
prehensive Organic Transformations, VCH, New York, 1999;
(e) J. R. Dunetz, J. Magano and G. A. Weisenburger, Org.
Process Res. Dev., 2016, 20, 140–177.
4 (a) R. Cadoni, A. Porcheddu, G. Giacomelli and L. D. Luca,
Org. Lett., 2012, 14, 5014–5017; (b) T. N. Reddy and
A. Beatriz, et al., Chem. – Asian J., 2019, 3, 344–388;
(c) R. M. de Figueiredo, J. S. Suppo and J. M. Campagne,
Chem. Rev., 2016, 116, 12029–12122.
Fig. 3 The proposed mechanism for the synthesis of amides.
carbene generated reacts with an aldehyde to form a Breslow
intermediate A, which subsequently gets oxidized to intermediate
B by the action of TBHP. In the next step, NHS attacks
intermediate B to give the corresponding NHS ester C and
imidazolium carbene, thus reviving the catalytic cycle. The NHS
ester formed reacts with the amine to produce the desired
amide D.
5 (a) E. Saxon and C. R. Bertozzi, Science, 2000, 287,
2007–2010; (b) F. Damkaci and P. De Shong, J. Am. Chem.
Soc., 2003, 125, 4408–4409; (c) Y. G. Gololobov and
L. F. Kasukhin, Tetrahedron, 1992, 48, 1353–1406.
6 (a) N. A. Owston, A. J. Parker and J. M. J. Williams, Org. Lett.,
2007, 9, 3599–3601; (b) M. Hashimoto, Y. Obora,
S. Sakaguchi and Y. Ishii, J. Org. Chem., 2008, 73, 2894–2897.
7 (a) T. Ribelin, C. E. Katz, D. G. English, S. Smith,
A. K. Manukyan, V. W. Day, B. Neuenswander,
J. L. Poutsma and J. Aube, Angew. Chem., Int. Ed., 2008,
47, 6233–6331; (b) S. Lang and J. A. Murphy, Chem. Soc. Rev.,
2006, 35, 146–156.
Conclusion
In conclusion, a novel and efficient methodology was developed
for the construction of various mono and di-substituted amides
in good yields by a cascade approach of the NHS ester
formation via aldehydes. This methodology is unique because
it utilizes readily available, non-hazardous, and cheaper starting
reagents and simple imidazolium-based N-heterocyclic carbenes.
Further attempts to explore the scope, limitation, and
mechanism of this reaction are underway in our laboratory.
8 D. J. C. Constable, P. J. Dunn, J. D. Hayler, G. R. Humphrey,
J. L. Leazer, Jr., R. J. Linderman, K. Lorenz, J. Manley,
B. A. Pearlman, A. Wells, A. Zaksh and T. Y. Zhang, Green
Chem., 2007, 9, 411–420.
9 (a) K. Ofele, J. Organomet. Chem., 1968, 12, 42–45;
¨
(b) H. W. Wanzlick and H. J. Schonherr, Angew. Chem., Int.
Ed. Engl., 1968, 7, 141–142; (c) A. J. Arduengo, R. L. Harlow
and M. Kline, J. Am. Chem. Soc., 1991, 113, 361–363;
(d) D. Ragno and A. Brandolese, et al., Chem. – Eur. J.,
2021, 27, 1839–1848; (e) C. Richter, M. Schedler and
F. Glorious, Nature, 2014, 510, 485–496.
Conflicts of interest
There are no conflicts of interest.
10 (a) A. J. Arduengo, M. Kline, J. C. Calabrese and F. Davidson,
J. Am. Chem. Soc., 1991, 113, 9704–9705; (b) L. Cavallo,
A. Correa, C. Costabile and H. Jacobsen, J. Organomet.
Chem., 2005, 690, 5407–5413; (c) R. S. Menon, A. T. Biju
and V. Nair, Chem. Soc. Rev., 2015, 44, 5040–5052;
(d) S. D. Sarkar, A. Biswas, R. C. Samanta and A. Studer,
Chem. – Eur. J., 2013, 19, 4664–4678.
11 (a) V. Kumar and S. J. Connon, Chem. Commun., 2017, 53,
10212–10215; (b) S. Premlatha, A. Ghosh and A. T. Biju,
et al., Chem. Commun., 2017, 53, 1478–1481; (c) R. A. Green,
D. Pletcher, S. G. Leach and R. C. D. Brown, Org. Lett., 2016,
18, 1198–1201; (d) P. Nagaraaj and V. Vijayakumar, Org.
Chem. Front., 2019, 6, 2570–2599.
Acknowledgements
The authors acknowledge the funding received from the Guru
Gobind Singh Indraprastha University for carrying out the
research experiments.
References
1 (a) T. Cupido, J. Tulla-Puche, J. Spengler and F. Albericio,
Curr. Opin. Drug Discovery Dev., 2007, 10, 768–783;
(b) J. W. Bode, Curr. Opin. Drug Discovery Dev., 2006, 9,
765–778; (c) J. M. Humphrey and A. R. Chamberlin, Chem.
Rev., 1997, 97, 2243–2266.
12 (a) C. E. I. Knappke, A. Imami and A. Jacobi von Wangelin,
ChemCatChem, 2012, 4, 937–940; (b) H. U. Vora and T. Rovis,
2 (a) A. K. Ghose, V. N. Viswanadhan and J. J. Wendoloski,
J. Comb. Chem., 1999, 1, 55–68; (b) Y. Zhang, D. Reimer,
This journal is © The Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2021
New J. Chem., 2021, 45, 7486–7490
| 7489